UNSPSC 85494674: Dilation of right pulmonary vein with drug-eluting intraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to dilation of right pulmonary vein with drug-eluting intraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 027S34Z

UNSPSC 85494674, Dilation of right pulmonary vein with drug-eluting intraluminal device, percutaneous approach, is a Commodity code that exhibits a fundamental mismatch between its clinical procedural description and actual state and local procurement activity. The recent opportunities posted under this code do not involve pulmonary vein interventions, drug-eluting devices, or percutaneous cardiology procedures; instead, they span occupational medical surveillance, independent medical evaluations for pension disability determinations, surgical benefit carve-outs, pharmacy benefit management, temporary clinical staffing, emergency youth detention healthcare, and health professional staffing pool qualification. This classification appears to be a data-entry or coding error rather than a reflection of genuine state and local purchasing in interventional cardiology or pulmonary medicine.

The issuers across these opportunities include state departments (Washington State Department of Transportation), counties (Harris County, Collier County, Santa Clara County), cities (Phoenix, Long Beach), and regional health systems (Santa Clara Health System). Opportunities were posted between late July and late August 2026, with response deadlines in September and October 2026, concentrated in California, Florida, Texas, Washington, and Arizona. Given the absence of any procurement activity aligned with the code's stated scope—invasive pulmonary vascular intervention—this code carries no actionable signal for vendors pursuing state and local contracts in medical device, cardiology, or interventional services. Firms should verify accurate code assignment before investing in pursuit under this commodity.